CU Anschutz Announces Study Using Groundbreaking Neuropixels Technology to Unlock New Insights into Parkinson’s Disease

The campus is the first site with FDA authorization to use this investigational device during brain surgery to study executive function AURORA, Colo., Sept. 30, 2025 /PRNewswire/ — Doctors at the University of Colorado Anschutz recently implanted an advanced Neuropixels technology into…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks